Back To Search Results

Papular Acrodermatitis

Editor: Noreen E. O'Shea Updated: 3/1/2024 1:21:04 AM

Introduction

Papular acrodermatitis of childhood, otherwise known as Gianotti-Crosti syndrome, is a benign rash associated with various viral illnesses.[1] Although historically thought to be solely a manifestation of hepatitis B infection, it has been demonstrated to occur following many viral illnesses and vaccination, which suggests that this is an immunologic response rather than a primary manifestation of infection. [2] Papular acrodermatitis of childhood is characterized by the acute eruption of monomorphic skin-colored to pink-red papules on the face, buttocks, and extensor surfaces of the extremities. The lesions usually spontaneously resolve, and treatment is supportive.[3][4][5]

Etiology

Register For Free And Read The Full Article
Get the answers you need instantly with the StatPearls Clinical Decision Support tool. StatPearls spent the last decade developing the largest and most updated Point-of Care resource ever developed. Earn CME/CE by searching and reading articles.
  • Dropdown arrow Search engine and full access to all medical articles
  • Dropdown arrow 10 free questions in your specialty
  • Dropdown arrow Free CME/CE Activities
  • Dropdown arrow Free daily question in your email
  • Dropdown arrow Save favorite articles to your dashboard
  • Dropdown arrow Emails offering discounts

Learn more about a Subscription to StatPearls Point-of-Care

Etiology

When papular acrodermatitis of childhood was initially described in the 1950s, it was believed to be a manifestation of hepatitis B virus infection. This was in large part due to the prevalence of anicteric hepatitis in these patients. Although this association is still common in hepatitis B endemic areas, it has been rare in the United States since the advent of the hepatitis B vaccine.

Ongoing studies have demonstrated that papular acrodermatitis of childhood can occur following a wide variety of viruses. These viruses include but are not limited to Epstein-Barr virus, cytomegalovirus, coxsackievirus, adenovirus, influenza, enteroviruses, echovirus, hepatitis A virus, herpes simplex viruses, human herpesvirus 6 (HHV-6), HIV, mumps, parainfluenza virus, parvovirus B19, poxviruses, respiratory syncytial virus, coronavirus, and rotavirus.[6][7] 

The condition has been reported after vaccination, including influenza, Calmette-Guerin bacillus, diphtheria-pertussis-tetanus, poliomyelitis, hepatitis B, Japanese encephalitis, yellow fever, and measles vaccines.[8] The Epstein-Barr virus is the most commonly reported cause of papular acrodermatitis of childhood in the United States. However, in many cases, no infectious trigger is identified. The relationship between these potential triggers and the manifestation of papular acrodermatitis of childhood is not well defined but is presumed to be immunologically mediated.[9][10][11][12][13][14]

Epidemiology

Reports of papular acrodermatitis of childhood are most common in children younger than 4 to 6 years of age, consistent with its viral etiology. In children, there is no sex predilection; however, in adulthood, it is slightly more common in female patients. There does not appear to be a genetic or familial predisposition in papular acrodermatitis of childhood. Most cases occur in spring and summer. Papular acrodermatitis of childhood occurs more often in children with atopic diseases, including atopic dermatitis. Although the disease is observed worldwide, the etiological agents exhibit geographic variations.[12][15][16]

Pathophysiology

The precise pathophysiology of papular acrodermatitis is unknown, but it is presumed to be immunologically mediated, given its association with viral infections and vaccination. Its increased prevalence in patients with a history of atopic disease, family history of atopic disease, or elevated immunoglobulin E also supports an immune-mediated pathology.[17] Proposed processes include immune complexes or delayed hypersensitivity reactions, but this has not been well defined to date.

Histopathology

Biopsy samples are not frequently taken from a patient of popular acrodermatitis as it is a benign condition and clinical diagnosis. The primary histological findings involve the dermis, reflecting the underlying immune response and vasculitic processes associated with the condition. Skin biopsies typically show a perivascular lymphocytic infiltrate, indicating an inflammatory reaction centered around blood vessels. This infiltrate consists mainly of lymphocytes. Additionally, there may be evidence of mild spongiosis and exocytosis in the epidermis, suggesting a secondary response to the immune activation.

The inflammatory changes in the blood vessel walls, consistent with a vasculitic component, may include endothelial swelling and perivascular fibrin deposition. Notably, the histopathological features are not pathognomonic for papular acrodermatitis and may overlap with other viral exanthems. Therefore, clinical correlation and consideration of the patient's medical history remain crucial for an accurate diagnosis. Overall, the histopathology of papular acrodermatitis underscores its immunologically mediated nature, emphasizing the transient and self-resolving nature of the skin lesions in this childhood dermatosis.[18]

History and Physical

As its name implies, papular acrodermatitis of childhood clinically manifests as an acute, symmetric eruption of flat-topped papules in an acral distribution. These monomorphic papules most commonly occur on the extensor surfaces of the extremities. Arms are more commonly involved than legs; the face, buttocks, palms, and soles may also be affected. The trunk and scalp are relatively spared, as are the popliteal and antecubital fossae. However, the involvement of any of these areas does not preclude the diagnosis of papular acrodermatitis of childhood.

The lesions are usually pale pink to flesh-colored and 1 to 10 mm in size. They tend to be larger in younger children and smaller in older children and adolescents. Rarely, lesions may be vesicular or hemorrhagic. They are firm and discrete; however, rarely, they can become confluent over pressure points like knees and elbows. Koebner phenomena, the accentuation of lesions at sites of trauma, has also been reported. Mild to moderate pruritus may also be present. 

Symptoms frequently last 2 to 4 weeks. In some cases, new lesions may appear for up to 8 to 11 weeks after the onset of illness. Importantly, the appearance of the rash itself may not help to distinguish the variously associated etiologies of papular acrodermatitis of childhood; however, careful assessment of associated or antecedent symptoms is essential for recognizing possible infectious triggers that may require further evaluation or isolation.

Usually, the rash resolves without any residual effects or scarring. Occasionally, hyperpigmentation or hypopigmentation may persist after the rash resolves.[12][19][20][21] There is no associated mucosal enanthem, but mucocutaneous features of the underlying viral trigger may be present.[21] Fever, lymphadenitis, and other symptoms such as hepatosplenomegaly or pharyngitis may be seen in association with the rash or preceding it. This is consistent with a variety of viral triggers for this entity.

There may also be a history of vaccination preceding the onset of the rash.[19][22] There are no specific laboratory findings seen in papular acrodermatitis of childhood. However, modest lymphocytosis or lymphopenia and elevated liver enzymes may be seen in Epstein-Barr virus, cytomegalovirus, or hepatitis-associated disease.[19]

Evaluation

In general, papular acrodermatitis of childhood is a clinical diagnosis with no laboratory testing indicated unless there are symptoms or physical exam findings, such as hepatomegaly, to suggest an underlying viral illness, such as hepatitis, that may require further management.

Proposed diagnostic criteria include:

  • Lesions lasting at least 10 days
  • 1- to 10-mm papules or papulovesicular lesions with involvement of 3 of the 4 following sites:
    • Extensor surfaces of the forearms
    • Extensor surfaces of the legs
    • Cheeks
    • Buttocks
  • Symmetrical distribution of lesions

Practitioners may need to further evaluate the causative virus in children who are immunocompromised or who reside in endemic areas. If a patient presents with jaundice, hepatomegaly, or generalized lymphadenopathy, evaluation for other viral infections, including hepatitis B or Epstein-Barr virus, may be indicated. Rarely, a skin biopsy may be performed to exclude other conditions in immunocompromised or other high-risk patients. Normally, biopsy findings are nonspecific, with dermal perivascular mononuclear cell infiltrates and capillary endothelial swelling.[23][24]

Treatment / Management

Practitioners should reassure patients that papular acrodermatitis of childhood is a benign and self-limited illness. The majority of cases spontaneously resolve without active intervention. Symptomatic management of itching may be helpful. Patients may use emollients or oral antihistamines. Since infectious agents do not directly cause skin lesions, mild-to-moderate potency topical steroids may be used in patients who fail to achieve relief of itching with emollients and oral antihistamines. However, treatment with topical steroids or oral antihistamines does not shorten the course of illness. Any underlying disorder, such as hepatitis B, that requires further management should be addressed. Lesions resolve without scarring, although postinflammatory pigmentary alteration may persist in some patients.[25](B3)

Differential Diagnosis

The differential diagnosis of papular acrodermatitis of childhood includes other viral exanthems such as erythema infectiosum and hand, foot, and mouth disease, insect bites, scabies, papular urticaria, atopic dermatitis, erythema multiforme, Langerhans cell histiocytosis, lichenoid dermatoses, and immunoglobulin A (IgA) vasculitis.

Prognosis

Papular acrodermatitis of childhood is a benign and self-limited disease that typically persists for 10 days to 6 months. The majority of skin manifestations resolve within 2 weeks to 2 months. Extracutaneous manifestations tend to persist longer than cutaneous lesions. Recurrences are rare.[22][26][27]

Complications

Postinflammatory hypopigmentation or hyperpigmentation may occur in darker skin phenotypes and persist for up to 6 months. Permanent scarring is uncommon. Complications may arise secondary to the underlying viral etiology.[19][28]

Deterrence and Patient Education

It is important to reassure parents about the benign nature of papular acrodermatitis of childhood to avoid unnecessary invasive testing or treatments. Further laboratory work-up is only indicated in high-risk patients, including those who are immunocompromised or from hepatitis B endemic areas. Additional testing is also suggested in those with extracutaneous symptoms suggestive of an underlying viral etiology, such as the Epstein-Barr virus. Excluding children from daycare, school, or social activities is not recommended.

Enhancing Healthcare Team Outcomes

Healthcare workers, including nurse practitioners and clinicians, need to be aware that papular acrodermatitis of childhood is a benign viral-induced skin disorder. It is often confused with other skin infections of childhood. If there is any doubt about the diagnosis, the patient should be referred to a dermatologist. Papular acrodermatitis of childhood is not person-to-person transmissible and does not require isolation beyond standard precautions or restrictions from school or other community activities. However, the associated viral infection may be contagious; thus, isolation may need to be considered based on other symptoms suggestive of infectious disease. The dermatologist and dermatologist nurse specialist should provide a team effort to educate patients and their families about the disease and the necessary precautions.

Media


(Click Image to Enlarge)
<p>Gianotti Crosti</p>

Gianotti Crosti

DermNet New Zealand

References


[1]

Oboli VN, Ebong IL, Tejada Amaro O, Regis JA, Waseem M. Gianotti-Crosti Syndrome: A Benign Dermatosis. Cureus. 2023 Jun:15(6):e40328. doi: 10.7759/cureus.40328. Epub 2023 Jun 12     [PubMed PMID: 37313283]


[2]

Afonso A, Cachão J, Pinto Junior VL, Gouveia T. Gianotti-Crosti syndrome: a challenging exanthema. BMJ case reports. 2021 Apr 1:14(4):. doi: 10.1136/bcr-2020-240747. Epub 2021 Apr 1     [PubMed PMID: 33795277]

Level 3 (low-level) evidence

[3]

Robl Imoto R Dr, Uber M, de Carvalho VO. Papular crusted rash in a child after immunisation. Archives of disease in childhood. 2019 Jul:104(7):706. doi: 10.1136/archdischild-2018-314922. Epub 2018 May 4     [PubMed PMID: 29728416]


[4]

Pedreira RL, Leal JM, Silvestre KJ, Lisboa AP, Gripp AC. Gianotti-Crosti syndrome: a case report of a teenager. Anais brasileiros de dermatologia. 2016 Sep-Oct:91(5 suppl 1):163-165. doi: 10.1590/abd1806-4841.20164410. Epub     [PubMed PMID: 28300930]

Level 3 (low-level) evidence

[5]

Drago F, Javor S, Ciccarese G, Parodi A. Gianotti-Crosti syndrome as presenting sign of cytomegalovirus infection: A case report and a critical appraisal of its possible cytomegalovirus etiology. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology. 2016 May:78():120-2. doi: 10.1016/j.jcv.2016.03.009. Epub 2016 Mar 19     [PubMed PMID: 27017141]

Level 3 (low-level) evidence

[6]

Swali RN, Lee EB, Adams JL. Gianotti-crosti syndrome in the setting of recent coronavirus disease-19 infection. Pediatric dermatology. 2021 May:38(3):629-631. doi: 10.1111/pde.14518. Epub 2021 Feb 28     [PubMed PMID: 33641205]


[7]

Dupont F, Aubry A, Lanoix JP, Demey B. Cytomegalovirus-Associated Gianotti-Crosti Syndrome in 28-Year-Old Immunocompetent Patient. Pathogens (Basel, Switzerland). 2022 Nov 12:11(11):. doi: 10.3390/pathogens11111338. Epub 2022 Nov 12     [PubMed PMID: 36422590]


[8]

Leal SBC, Balconi SN, Cafrune FE. Gianotti-Crosti syndrome and yellow fever vaccine: unprecedented reaction. International journal of dermatology. 2021 Jun:60(6):e227-e228. doi: 10.1111/ijd.15381. Epub 2020 Dec 23     [PubMed PMID: 33368195]


[9]

Gianotti F, Pesapane F, Gianotti R. Ferdinando Gianotti and the papular acrodermatitis of childhood: a scientist against all the odds. JAMA dermatology. 2014 May:150(5):485. doi: 10.1001/jamadermatol.2013.10445. Epub     [PubMed PMID: 24827010]


[10]

Llanora GV, Tay CM, van Bever HP. Gianotti-Crosti syndrome: case report of a pruritic acral exanthema in a child. Asia Pacific allergy. 2012 Jul:2(3):223-6. doi: 10.5415/apallergy.2012.2.3.223. Epub 2012 Jul 25     [PubMed PMID: 22872825]

Level 3 (low-level) evidence

[11]

Leung AKC, Sergi CM, Lam JM, Leong KF. Gianotti-Crosti syndrome (papular acrodermatitis of childhood) in the era of a viral recrudescence and vaccine opposition. World journal of pediatrics : WJP. 2019 Dec:15(6):521-527. doi: 10.1007/s12519-019-00269-9. Epub 2019 May 27     [PubMed PMID: 31134587]


[12]

Taïeb A, Plantin P, Du Pasquier P, Guillet G, Maleville J. Gianotti-Crosti syndrome: a study of 26 cases. The British journal of dermatology. 1986 Jul:115(1):49-59     [PubMed PMID: 3015187]

Level 3 (low-level) evidence

[13]

Drago F, Crovato F, Rebora A. Gianotti-Crosti syndrome as a presenting sign of EBV-induced acute infectious mononucleosis. Clinical and experimental dermatology. 1997 Nov:22(6):301-2     [PubMed PMID: 9604462]

Level 3 (low-level) evidence

[14]

Hofmann B, Schuppe HC, Adams O, Lenard HG, Lehmann P, Ruzicka T. Gianotti-Crosti syndrome associated with Epstein-Barr virus infection. Pediatric dermatology. 1997 Jul-Aug:14(4):273-7     [PubMed PMID: 9263306]


[15]

Caputo R, Gelmetti C, Ermacora E, Gianni E, Silvestri A. Gianotti-Crosti syndrome: a retrospective analysis of 308 cases. Journal of the American Academy of Dermatology. 1992 Feb:26(2 Pt 1):207-10     [PubMed PMID: 1552055]

Level 2 (mid-level) evidence

[16]

Brown J, Rentiers P. The Gianotti-Crosti syndrome: a distrinctive exanthem. Canadian Medical Association journal. 1969 Apr 26:100(16):773-4     [PubMed PMID: 5780747]


[17]

Bassi A, Pedaci F, Oranges T, Azzari C, Galli L, Ricci S, Filippeschi C, Venturini E. The Serum Immunoglobulin E Level: Is There a Relationship With the Clinical Course of the Gianotti-Crosti Syndrome? Frontiers in pediatrics. 2021:9():643341. doi: 10.3389/fped.2021.643341. Epub 2021 Feb 25     [PubMed PMID: 33718308]


[18]

Milbradt R, Nasemann T. [Entity of the Gianotti-Crosti's syndrome and its relation to hepatitis B infection]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete. 1975 Sep:26(9):471-9     [PubMed PMID: 1184390]


[19]

Brandt O, Abeck D, Gianotti R, Burgdorf W. Gianotti-Crosti syndrome. Journal of the American Academy of Dermatology. 2006 Jan:54(1):136-45     [PubMed PMID: 16384769]


[20]

Chuh AA. Truncal lesions do not exclude a diagnosis of Gianotti-Crosti syndrome. The Australasian journal of dermatology. 2003 Aug:44(3):215-6     [PubMed PMID: 12869049]

Level 3 (low-level) evidence

[21]

Tilly JJ, Drolet BA, Esterly NB. Lichenoid eruptions in children. Journal of the American Academy of Dermatology. 2004 Oct:51(4):606-24     [PubMed PMID: 15389198]


[22]

Chuh A, Lee A, Zawar V. The diagnostic criteria of Gianotti-Crosti syndrome: are they applicable to children in India? Pediatric dermatology. 2004 Sep-Oct:21(5):542-7     [PubMed PMID: 15461758]

Level 2 (mid-level) evidence

[23]

Liaw FY, Huang CF, Wu LW, Chiang CP. Acral papular rash in a 2-year-old boy. The Journal of family practice. 2012 Mar:61(3):157-9     [PubMed PMID: 22393556]

Level 3 (low-level) evidence

[24]

Bilenchi R, De Paola M, Poggiali S, Acciai S, Feci L, Sansica P, Fimiani M. Papular-purpuric "gloves and socks" syndrome. Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia. 2012 Feb:147(1):119-21     [PubMed PMID: 22370576]

Level 3 (low-level) evidence

[25]

Boeck K, Mempel M, Schmidt T, Abeck D. Gianotti-Crosti syndrome: clinical, serologic, and therapeutic data from nine children. Cutis. 1998 Dec:62(6):271-4; quiz 286     [PubMed PMID: 9878981]

Level 3 (low-level) evidence

[26]

Patrizi A, Di Lernia V, Neri I, Ricci G. An unusual case of recurrent Gianotti-Crosti syndrome. Pediatric dermatology. 1994 Sep:11(3):283-4     [PubMed PMID: 7971574]

Level 3 (low-level) evidence

[27]

Lee S, Kim KY, Hahn CS, Lee MG, Cho CK. Gianotti-Crosti syndrome associated with hepatitis B surface antigen (subtype adr). Journal of the American Academy of Dermatology. 1985 Apr:12(4):629-33     [PubMed PMID: 3989023]

Level 3 (low-level) evidence

[28]

Gabrielsen TO, Rajka G, Rustenberg B. [Acrodermatitis papulosa eruptiva infantum as a prodrome in hepatitis B infection]. Zeitschrift fur Hautkrankheiten. 1985 Nov 15:60(22):1793-6     [PubMed PMID: 4082695]

Level 3 (low-level) evidence